New patent expiration for Novartis Pharms drug PROMACTA

00:09 EDT 30 Apr 2019 | BiotechBlog

Annual Drug Patent Expirations for PROMACTA Promacta is a drug marketed by Novartis Pharms Corp and is included in two NDAs. It is available from two suppliers. There are thirteen…
The post New patent expiration for Novartis Pharms drug PROMACTA appear...

The post New patent expiration for Novartis Pharms drug PROMACTA appeared first on Biotechblog.

Original Article: New patent expiration for Novartis Pharms drug PROMACTA

More From BioPortfolio on "New patent expiration for Novartis Pharms drug PROMACTA"